CSCI: COSCIENS Biopharma Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.68
Enterprise Value ($M) -8.31
Book Value ($M) 20.01
Book Value / Share 5.33
Price / Book 0.58
NCAV ($M) 4.47
NCAV / Share 1.19
Price / NCAV 2.62

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.63
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 3.05
Current Ratio 3.46

Balance Sheet (mrq) ($M)
Current Assets 28.22
Assets 43.77
Liabilities 23.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-20 13D/A Goodwood Inc. 8.20 16.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 17,813 56,818 31.35
2025-03-13 23,950 154,588 15.49
2025-03-12 2,580 3,431 75.20
2025-03-11 315 902 34.92
2025-03-10 3,435 11,795 29.12

(click for more detail)

Similar Companies
CRIS – Curis, Inc. CRVO – CervoMed Inc.
CSBR – Champions Oncology, Inc. CTXR – Citius Pharmaceuticals, Inc.
CUE – Cue Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io